Three Months of Treatment With Esketamine: Effects on Depression, Insomnia, and Weight

Prim Care Companion CNS Disord. 2020 Jul 9;22(4):19l02555. doi: 10.4088/PCC.19l02555.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Intranasal
  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / pharmacology*
  • Body Weight / drug effects*
  • Depressive Disorder, Treatment-Resistant / complications
  • Depressive Disorder, Treatment-Resistant / drug therapy*
  • Female
  • Humans
  • Ketamine / administration & dosage
  • Ketamine / pharmacology*
  • Middle Aged
  • Sleep Initiation and Maintenance Disorders / drug therapy*
  • Sleep Initiation and Maintenance Disorders / etiology
  • Time Factors

Substances

  • Antidepressive Agents
  • Esketamine
  • Ketamine